Healthcare >> CEO Interviews >> October 5, 2000
DR. GEORGE A. SCANGOS, President and Chief Executive Officer, joined
Exelixis, Inc. in October 1996 from Bayer Biotechnology. At Bayer he
held positions of increasing responsibility, from Senior Staff Scientist
to Senior Vice President of Research and Development for North America
and ultimately, President of Bayer Biotechnology. As President of Bayer
Biotechnology, Dr. Scangos was responsible for 1,100 employees in
research and development, business development, process development,
manufacturing, engineering, and quality assurance. Prior to Bayer, Dr.
Scangos was on the faculty of the Johns Hopkins University, where he now
holds an appointment as Adjunct Professor of Biology. Dr. Scangos holds
a PhD. in Microbiology from the University of Massachusetts, and was a
Jane Coffin Childs Postdoctoral Fellow. Profile
Dr. Scangos: Exelixis was founded in late 1994. Officially, it began
operations in early 1995. It was founded as a fruit fly
